SNAP-8 is a topical cosmetic ingredient
SNAP-8 is a trade name for acetyl octapeptide-3 used in topical cosmetics. It is not botulinum toxin, not an injectable treatment, and not an FDA-approved drug. Finished serums also contain vehicles, preservatives, and other actives that affect penetration, tolerability, and performance.
Direct human evidence is not established
The commonly cited peer-reviewed human study concerns acetyl hexapeptide-8 (Argireline), a related but different molecule—not acetyl octapeptide-3.[1] Manufacturer percentages, mechanism diagrams, and findings for a related peptide do not establish that every SNAP-8 formulation reduces wrinkles. Teloryx found no robust independent randomized human trial directly validating SNAP-8 itself.
“Botox-like” is misleading
Marketing proposes interference with neurotransmitter-release machinery, but topical delivery and clinical effect are uncertain. FDA-approved botulinum toxin products use a different active ingredient, injection route, pharmacology, dose, and evidence program. Similar marketing language does not make the products therapeutically equivalent.
Safety and regulatory status
U.S. cosmetics generally do not receive FDA premarket approval, although companies remain responsible for safety and lawful labeling.[2] Irritation or allergy may arise from the peptide or other formula ingredients. FDA advises stopping a cosmetic and seeking appropriate care for a serious reaction.[3] Teloryx presents SNAP-8 only as an evidence-limited topical cosmetic ingredient and provides no injection guidance.